New Medicare payment rules could impact hospitals nationwide in 2027

A modest Medicarepay rise may not be enough to calm hospitals facing a more complicated 2027. The Centers for Medicare & Medicaid Services has proposed new payment rules that would increase rates for many facilities, while also expanding financial risk, tightening reimbursement pathways and leaving rural hospitals exposed to a looming funding deadline.

The proposed rule covers general acute care hospital inpatient services and long-term care hospital inpatient services for fiscal year 2027. Comments are due by June 9, 2026, giving hospitals, compliance teams and lawmakers a short window to respond before the final version takes shape.

CMS is proposing a 2.4% payment increase for inpatient prospective payment system hospitals and long-term care hospitals. For acute care hospitals, the figure reflects a 3.2% market basket update reduced by a 0.8 percentage point productivity adjustment.

The agency estimates the change would increase acute care hospital payments by about $1.4 billion nationwide.

But the proposed increase comes with major policy changes that could affect how hospitals manage surgeries, residency programs, organ acquisition costs and new medical technology.

The most immediate concern for many small hospitals is not the proposed rate increase, but what happens if Congress fails to act before the end of 2026.

Two key rural payment supports, the Medicare Dependent Hospital program and the low-volume hospital adjustment, are scheduled to expire on December 31, 2026. Without an extension, qualifying hospitals would revert to less favorable payment rules beginning January 1, 2027.

The Medicare Dependent Hospital program helps small rural hospitals with fewer than 100 beds and a high percentage of Medicare discharges. The low-volume adjustment supports hospitals with fewer than 3,800 total discharges that are located more than 15 road miles from another hospital.

CMS estimates that extending both programs through fiscal year 2027 would provide about $400 million in additional payments.

For rural hospitals already under pressure from staffing shortages, service cuts and tight margins, the deadline could become a major financial test.

New surgical model puts hospitals at risk

CMS is also proposing a mandatory nationwide episode-based payment model known as CJR-X, beginning October 1, 2027. The model would expand the Comprehensive Care for Joint Replacement approach to eligible acute care hospitals across the country.

CJR-X would cover lower extremity joint replacement surgeries, including hip, knee and ankle procedures, in both inpatient and hospital outpatient settings. Hospitals would be accountable for spending and quality during the procedure and for 90 days after discharge.

Facilities that keep costs below risk-adjusted and quality-adjusted targets could receive reconciliation payments. Hospitals that exceed those targets would have to repay CMS.

The agency estimates CJR-X could save Medicare about $725 million over five performance years.

Hospitals already participating in the Transforming Episode Accountability Model, known as TEAM, would be exempt from CJR-X until TEAM ends.

TEAM began January 1, 2026 and covers five surgical episode categories, including joint replacement, coronary artery bypass graft and spinal fusion.

Teaching hospitals and technology payments face scrutiny

The proposed rule also includes changes to graduate medical education reimbursement. CMS wants to apply new non-discrimination requirements to residency programs and Medicare-reimbursed nursing and allied health programs.

The agency is also proposing tighter rules for identifying “new” residency programs when calculating direct graduate medical education and indirect medical education payments. In most cases, at least 90% of residents would need to have no prior training in the same specialty.

Another major change would affect new technology add-on payments. CMS proposes continuing payments for 41 technologies in fiscal 2027, but would eliminate the alternative pathway from 2028 onward.

That means breakthrough devices and certain infectious disease products would generally need to prove substantial clinical improvement over existing options.

For hospitals, the message is clear. The proposed 2027 Medicare rule offers more money at the top line, but also more accountability, more documentation pressure and more uncertainty.

The final rule could determine whether hospitals enter 2027 with modest relief or a new wave of financial strain.